Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3368)
Entrada Therapeutics, Inc. (TRDA)
Dowden Nathan J — President & COO
Shares
3,116
Price
$13.02
Total Value
$40.58K
Shares Held After
210,482
% of Holdings
1.5%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
247
Price
$2.54
Total Value
$626.39
Shares Held After
514,304
% of Holdings
0.0%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
2,000
Price
$11.21
Total Value
$22.42K
Shares Held After
7,450
% of Holdings
26.8%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
181,219
Price
$2.00
Total Value
$362.44K
Shares Held After
62,586
% of Holdings
74.3%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
65,000
Price
$62.06
Total Value
$4.03M
Shares Held After
6,000
% of Holdings
91.5%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
61,652
Price
$60.08
Total Value
$3.70M
Shares Held After
6,000
% of Holdings
91.1%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
43,348
Price
$59.26
Total Value
$2.57M
Shares Held After
72,652
% of Holdings
37.4%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
2,449
Price
$61.26
Total Value
$150.03K
Shares Held After
6,000
% of Holdings
29.0%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
10,072
Price
$60.47
Total Value
$609.05K
Shares Held After
8,449
% of Holdings
54.4%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
12,479
Price
$59.50
Total Value
$742.50K
Shares Held After
18,521
% of Holdings
40.3%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
21,515
Price
$60.49
Total Value
$1.30M
Shares Held After
6,000
% of Holdings
78.2%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
31,694
Price
$59.88
Total Value
$1.90M
Shares Held After
27,515
% of Holdings
53.5%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
21,791
Price
$58.81
Total Value
$1.28M
Shares Held After
59,209
% of Holdings
26.9%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
200
Price
$10.17
Total Value
$2.03K
Shares Held After
21,706
% of Holdings
0.9%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Title: Chief Technology and Manufacturing Officer
Shares
479
Price
$2.54
Total Value
$1.21K
Shares Held After
525,503
% of Holdings
0.1%
Entera Bio Ltd. (ENTX)
Germano Geno J — Director
Shares
20,000
Price
$1.30
Total Value
$26.00K
Shares Held After
40,000
% of Holdings
50.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,171
Price
$26.84
Total Value
$58.27K
Shares Held After
82,489
% of Holdings
2.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Caudill Cortney — SVP, CHIEF OPERATING OFFICER
Shares
2,100
Price
$68.25
Total Value
$143.33K
Shares Held After
14,366
% of Holdings
12.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Caudill Cortney — SVP, CHIEF OPERATING OFFICER
Shares
17,900
Price
$67.75
Total Value
$1.21M
Shares Held After
16,466
% of Holdings
52.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$529.83
Total Value
$42.39K
Shares Held After
130
% of Holdings
38.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
678
Price
$528.85
Total Value
$358.56K
Shares Held After
210
% of Holdings
76.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,066
Price
$527.95
Total Value
$562.80K
Shares Held After
888
% of Holdings
54.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$526.60
Total Value
$126.38K
Shares Held After
1,954
% of Holdings
10.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$524.85
Total Value
$62.98K
Shares Held After
2,194
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
165
Price
$523.52
Total Value
$86.38K
Shares Held After
2,314
% of Holdings
6.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
335
Price
$522.02
Total Value
$174.88K
Shares Held After
2,479
% of Holdings
11.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
465
Price
$520.87
Total Value
$242.20K
Shares Held After
2,814
% of Holdings
14.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$519.99
Total Value
$270.40K
Shares Held After
3,279
% of Holdings
13.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
361
Price
$518.80
Total Value
$187.29K
Shares Held After
3,799
% of Holdings
8.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$517.83
Total Value
$165.19K
Shares Held After
4,160
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
588
Price
$516.64
Total Value
$303.79K
Shares Held After
4,479
% of Holdings
11.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
678
Price
$515.81
Total Value
$349.72K
Shares Held After
5,067
% of Holdings
11.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
565
Price
$514.90
Total Value
$290.92K
Shares Held After
5,745
% of Holdings
9.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
676
Price
$513.65
Total Value
$347.23K
Shares Held After
6,310
% of Holdings
9.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
603
Price
$512.88
Total Value
$309.27K
Shares Held After
6,986
% of Holdings
7.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
896
Price
$511.73
Total Value
$458.51K
Shares Held After
7,589
% of Holdings
10.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
701
Price
$510.81
Total Value
$358.07K
Shares Held After
8,485
% of Holdings
7.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
244
Price
$509.49
Total Value
$124.32K
Shares Held After
9,186
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$500.05
Total Value
$100.01K
Shares Held After
9,430
% of Holdings
2.1%
ADMA BIOLOGICS, INC. (ADMA)
Kestenberg-Messina Kaitlin M. — COO and SVP, Compliance
Shares
10,096
Price
$15.63
Total Value
$157.80K
Shares Held After
466,600
% of Holdings
2.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,941
Price
$14.79
Total Value
$457.62K
Shares Held After
647,809
% of Holdings
4.6%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
6,693
Price
$16.08
Total Value
$107.63K
Shares Held After
451,815
% of Holdings
1.5%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,931
Price
$60.72
Total Value
$481.57K
Shares Held After
391,673
% of Holdings
2.0%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
2,907
Price
$60.72
Total Value
$176.51K
Shares Held After
138,629
% of Holdings
2.1%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
2,582
Price
$60.72
Total Value
$156.78K
Shares Held After
47,858
% of Holdings
5.1%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$19.03
Total Value
$951.47K
Shares Held After
964,161
% of Holdings
4.9%
Jazz Pharmaceuticals plc (JAZZ)
Carr Patricia — SVP, Chief Accounting Officer
Shares
1,287
Price
$182.94
Total Value
$235.44K
Shares Held After
6,512
% of Holdings
16.5%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
101,409
Price
$30.29
Total Value
$3.07M
Shares Held After
69,302
% of Holdings
59.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$484.27
Total Value
$77.48K
Shares Held After
130
% of Holdings
55.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
450
Price
$483.69
Total Value
$217.66K
Shares Held After
290
% of Holdings
60.8%
Showing 451–500 of 3368 transactions (page 10 of 68)